Pair up with one of the Academy's experienced and credentialed providers for one-on-one guidance. No matter where you are on your journey, an Academy Mentor can help you reach your personal goals.
Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010 Fe 25;362(8)697-706.
Abdool K SS, Naidoo K, Grobler A, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011 Oct 20;365(16):1492-501.
Aberg JA, Tebas P, Overton ET, Gupta SK, Sax PE, Landay A, et al. Metabolic effects of darunavir/ritonavir versus ataznavir/ritonavir in treatment-naïve, HIV type 1-infected subjects over 48 weeks. AIDS Res Hum Retroviruses 2012; 28(10):1184-95.
Aberg JA, Gallant JE, Ghanem KG, et al. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. Clin Infect Dis. 2014;58:1-34.